The device is worn by patients at risk of ventricular tachycardia or ventricular fibrillation during their hospital stays to monitor for irregular heart rhythms.
When the Hospital Wearable Defibrillator detects a life-threatening heart rhythm, it alerts the patient prior to administering a treatment shock. The device is programmed to deliver fibrillation within 60 seconds of the detected irregularity, according to a company news release.
More articles on supply chain:
Viewpoint: Trump is ‘crying wolf’ on drug price measures
6 must-reads for supply chain leaders this week
Trump nominates Dr. Scott Gottlieb for FDA commissioner: 6 things to know
